Data / Form D filings / Lodestone Biomedical, Inc.
Lodestone Biomedical, Inc.: Form D filings
Lodestone Biomedical, Inc., a biotechnology company in Lebanon, NH, filed 4 Form D notices with the SEC between 2017 and 2025. The latest, on July 9, 2025, reports $75,000 sold of a $2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 WATER STREET, SUITE 265, Lebanon, NH, 03766
- Phone
- (617) 686-5517
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1710677
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | New notice | $2,000,000 | $75,000 | $1,925,000 | 1 | Jun 29, 2025 | sec.gov |
| Dec 14, 2021 | New notice | $1,000,000 | $450,000 | $550,000 | 6 | Dec 1, 2021 | sec.gov |
| Apr 6, 2020 | New notice | $400,000 | $110,000 | $290,000 | 3 | Mar 17, 2020 | sec.gov |
| Jul 13, 2017 | New notice | $600,000 | $550,000 | $50,000 | 7 | Jul 6, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Solomon Diamond | Executive Officer, Director |
Every Form D from the week of Jul 7, 2025 · All recent filings in New Hampshire · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lodestone Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.